Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Medlab Clinical stock

MDC.AX
AU000000MDC8
A14R7W

Price

6.60
Today +/-
+0
Today %
+0 %
P

Medlab Clinical stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Medlab Clinical stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Medlab Clinical stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Medlab Clinical stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Medlab Clinical's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Medlab Clinical Stock Price History

DateMedlab Clinical Price
11/7/20246.60 undefined
11/6/20246.60 undefined
11/5/20246.60 undefined
11/4/20246.60 undefined
11/1/20246.60 undefined
10/31/20246.60 undefined
10/30/20246.60 undefined
10/29/20246.60 undefined
10/28/20246.60 undefined
10/25/20246.60 undefined
10/24/20246.60 undefined
10/23/20246.60 undefined
10/22/20246.60 undefined
10/21/20246.60 undefined
10/18/20246.60 undefined
10/17/20246.60 undefined
10/16/20246.60 undefined
10/15/20246.60 undefined
10/14/20246.60 undefined
10/11/20246.60 undefined
10/10/20246.60 undefined

Medlab Clinical Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Medlab Clinical, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Medlab Clinical from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Medlab Clinical’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Medlab Clinical. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Medlab Clinical’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Medlab Clinical’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Medlab Clinical’s growth potential.

Medlab Clinical Revenue, EBIT and net profit per share

DateMedlab Clinical RevenueMedlab Clinical EBITMedlab Clinical Net Income
2027e20.9 M undefined0 undefined-9.9 M undefined
2026e17.9 M undefined-14.2 M undefined-8.05 M undefined
2025e6.87 M undefined-5.96 M undefined-2.51 M undefined
2024e4.38 M undefined-21.84 M undefined-21.74 M undefined
2023943,670 undefined-7.22 M undefined-6.78 M undefined
20221.33 M undefined-8.37 M undefined-7.16 M undefined
2021757,930 undefined-10.93 M undefined-6.78 M undefined
20202.92 M undefined-13.74 M undefined-13.4 M undefined
20197.8 M undefined-8.39 M undefined-8.09 M undefined
20185.55 M undefined-4.7 M undefined-4.57 M undefined
20174.45 M undefined-3.82 M undefined-3.66 M undefined
20162.61 M undefined-3.71 M undefined-3.49 M undefined
20151.27 M undefined-3.9 M undefined-3.55 M undefined
2014590,000 undefined-1.8 M undefined-1.61 M undefined

Medlab Clinical Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
20142015201620172018201920202021202220232024e2025e2026e2027e
0124572010461720
--100.00100.0025.0040.00-71.43----50.00183.3317.65
-100.0050.0050.0060.0057.14--------
01123400000000
-1-3-3-3-4-8-13-10-8-7-21-5-140
--300.00-150.00-75.00-80.00-114.29-650.00--800.00--525.00-83.33-82.35-
-1-3-3-3-4-8-13-6-7-6-21-2-8-9
-200.00--33.33100.0062.50-53.8516.67-14.29250.00-90.48300.0012.50
74.1874.18168.931.171.281.391.51.972.282.280000
--------------
Details

Keystats

ⓘ

Revenue and Growth

The Medlab Clinical Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Medlab Clinical is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (k)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (k)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (k)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (k)SHORT-TERM DEBTS (k)LONG-TERM DEBT PORTION (k)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (k)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
2014201520162017201820192020202120222023
                   
1.080.120.81.520.3311.449.0613.435.190.23
0.940.841.141.72.061.80.781.040.080.1
000002.012.62.313.792.76
0.230.390.690.761.162.221.470.790.080
0.10.390.140.230.261.620.510.50.10
2.351.742.774.1923.8119.0914.4218.089.243.09
0.580.540.50.450.440.632.882.081.420
0000000000
00000482.85482.94482.54709.2150
0000000000
0000000000
00056.4174.4500000
0.580.540.50.510.511.113.362.572.120.05
2.932.283.274.724.3320.217.7920.6511.373.14
                   
5.255.2510.6115.639.1641.6251.3666.8166.8166.81
0000000000
-2.69-4.63-8.13-11.78-16.35-26.64-40.04-51.67-58.83-65.53
-2006062.0468.0468.871.9878.2699.96101.840
0000000000
2.360.682.553.8822.8815.0511.415.848.081.28
0.280.890.911.061.592.551.821.480.531.22
0.060.080.150.190.261.381.341.551.090.32
0000081.43553.9785.65690.4310.35
076019.5332.27499.7971.9894.2267.8300
000000609.81638.07568.230
0.341.731.071.292.354.984.434.522.881.85
0.240.250.250.26001.630.990.550
0000000000
04047.9893.58118.62228.24477.67232.72186.2213.55
0.240.290.30.360.120.232.111.220.740.01
0.582.021.371.652.475.216.535.743.621.86
2.942.73.925.5325.3520.2617.9321.5811.73.14
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Medlab Clinical provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Medlab Clinical's financial health and stability.

Assets

Medlab Clinical's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Medlab Clinical must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Medlab Clinical after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Medlab Clinical's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (k)CASH FLOW FROM OTHER INVESTING ACTIVITIES (k)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
201420152016201720182019202020212022
0000000-12-7
000000000
000000000
000011233
00000000-1
000000000
000000000
-2-3-3-4-4-10-10-10-9
000000000
000000001,000
000000001,000
000000000
000000-100
336524110160
33442318140
-----1.00---1.00-
000000000
-1-4-4-413-20-15-9-20
-2.42-4.16-3.98-4.33-4.87-10.66-10.67-10.44-9.3
000000000

Medlab Clinical stock margins

The Medlab Clinical margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Medlab Clinical. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Medlab Clinical.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Medlab Clinical's sales revenue. A higher gross margin percentage indicates that the Medlab Clinical retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Medlab Clinical's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Medlab Clinical's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Medlab Clinical's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Medlab Clinical. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Medlab Clinical's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Medlab Clinical Margin History

Medlab Clinical Gross marginMedlab Clinical Profit marginMedlab Clinical EBIT marginMedlab Clinical Profit margin
2027e90.35 %0 %-47.37 %
2026e90.35 %-79.33 %-44.97 %
2025e90.35 %-86.76 %-36.55 %
2024e90.35 %-498.27 %-495.97 %
202390.35 %-765.6 %-718.3 %
202273.38 %-630.61 %-539.68 %
202193.17 %-1,441.95 %-895.07 %
20202.95 %-469.67 %-458.17 %
201959.64 %-107.57 %-103.79 %
201863.62 %-84.8 %-82.4 %
201761.2 %-85.96 %-82.26 %
201666.96 %-142.13 %-133.72 %
201592.05 %-307.87 %-280.6 %
201498.31 %-305.08 %-272.88 %

Medlab Clinical Stock Sales Revenue, EBIT, Earnings per Share

The Medlab Clinical earnings per share therefore indicates how much revenue Medlab Clinical has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Medlab Clinical earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Medlab Clinical's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Medlab Clinical’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Medlab Clinical's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Medlab Clinical Revenue, EBIT and net profit per share

DateMedlab Clinical Sales per ShareMedlab Clinical EBIT per shareMedlab Clinical Earnings per Share
2027e9.17 undefined0 undefined-4.34 undefined
2026e7.85 undefined0 undefined-3.53 undefined
2025e3.01 undefined0 undefined-1.1 undefined
2024e1.92 undefined0 undefined-9.53 undefined
20230.41 undefined-3.16 undefined-2.97 undefined
20220.58 undefined-3.67 undefined-3.14 undefined
20210.39 undefined-5.56 undefined-3.45 undefined
20201.94 undefined-9.13 undefined-8.9 undefined
20195.59 undefined-6.02 undefined-5.81 undefined
20184.35 undefined-3.69 undefined-3.58 undefined
20173.78 undefined-3.25 undefined-3.11 undefined
20160.02 undefined-0.02 undefined-0.02 undefined
20150.02 undefined-0.05 undefined-0.05 undefined
20140.01 undefined-0.02 undefined-0.02 undefined

Medlab Clinical business model

Medlab Clinical Ltd is an innovative biotechnology company focused on the development and commercialization of medical products and services. The company was founded in Australia in 2012 and is now based in Sydney. Since its founding, Medlab has established itself as a leading provider of diagnostic and therapeutic products. Medlab's business model consists of three different divisions. The first division is pharmaceutical development, where Medlab works on the development of new medications for the treatment of conditions such as fibromyalgia, pain, or ADHD. Medlab is particularly innovative in the development of medications based on the use of cannabinoids that are approved for medical use. The second division of Medlab is the research and development of nutritional supplements. The company works on the development of innovative products to improve general well-being and support health. An example is the nutritional supplement NRGBiotic, which contains special probiotic bacteria that help regulate the intestinal flora and thereby strengthen the immune system. The third division of Medlab is clinical diagnostics. The company offers various medical diagnostic tests, such as the test for food intolerances. This test is based on a blood sample and allows for targeted dietary changes in individuals with intolerance. Medlab aims to improve people's lives by developing and providing innovative products and services for medical care. Medlab's products are designed to promote the health and well-being of patients and customers and improve their quality of life. One outstanding product from Medlab is NanoCBD, an innovative form of cannabinoid delivery for medical purposes. The advantage of NanoCBD is that it has increased bioavailability due to the nanoparticles, resulting in faster and more effective action than conventional CBD products. Another product from Medlab is the pain medication NanaBis, which works faster and more effectively than other pain medications due to its unique formulation. Thanks to its special composition, NanaBis can also be taken by patients with severe chronic pain who do not respond to other pain medications. Medlab has established itself as a global company and is present worldwide. The company maintains partnerships and collaborations with renowned research institutions and doctors in Europe, North America, Australia, and Asia. Medlab works closely with medical professionals to ensure that the company's products and services meet the highest quality standards and meet the needs of patients and customers. Overall, Medlab Clinical Ltd has established itself as an innovative and reliable company in the medical industry. With its clear focus on the development of innovative medications, nutritional supplements, and diagnostic systems, Medlab significantly contributes to improving the healthcare system and increasing the well-being of people worldwide. Medlab Clinical is one of the most popular companies on Eulerpool.com.

Medlab Clinical Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Medlab Clinical historical P/E ratio, EBIT multiple, and P/S ratio

Medlab Clinical shares outstanding

The number of shares was Medlab Clinical in 2023 — This indicates how many shares 2.284 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Medlab Clinical earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Medlab Clinical's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Medlab Clinical’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Medlab Clinical's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Medlab Clinical stock splits

In Medlab Clinical's history, there have been no stock splits.

The World’s Best Investors Are On Eulerpool

Unfortunately, there are currently no price targets and forecasts available for Medlab Clinical.

Medlab Clinical shareholders

%
Name
Stocks
Change
Date
17.06316 % Hall (Sean Michael)389,040-3,3333/25/2024
9.02031 % Farjoy Pty. Ltd.205,66304/24/2024
3.31417 % Fit Investments Pty. Ltd.75,56304/24/2024
2.39934 % Realm Group Pty. Ltd.54,705-15,2954/24/2024
1.62447 % Albarran (Richard)37,03804/24/2024
1.62447 % Rolay Pty. Ltd.37,03804/24/2024
1.44605 % United Trolley Collections Pty. Ltd.32,97004/24/2024
1.30789 % Hall Jones Superannuation Fund29,82004/24/2024
0.87719 % Villamagna Inc.20,00004/24/2024
0.84741 % Netwealth Investments Ltd.19,3214824/24/2024
1
2

Medlab Clinical Executives and Management Board

Mr. Laurence McAllister
Medlab Clinical Non-Executive Director (since 2020)
Compensation 620,500
Mr. Sean Hall
Medlab Clinical Chief Executive Officer, Managing Director, Executive Director
Compensation 574,110
Mr. Kerem Kaya
Medlab Clinical Chief Financial Officer, Chief Operating Officer, Company Secretary
Compensation 292,829
Mr. Ian Curtinsmith
Medlab Clinical Chief Information Officer
Compensation 234,421
Dr. David Rutolo
Medlab Clinical Director of Science
Compensation 187,440
1
2

Medlab Clinical Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Nitto Denko Stock
Nitto Denko
SupplierCustomer0,09-0,71-0,56-0,07-0,250,34
Microsoft Stock
Microsoft
SupplierCustomer0,020,230,220,810,05-0,46
Tilray Brands 2 Stock
Tilray Brands 2
SupplierCustomer-0,240,48-0,210,510,750,72
Aphria, Inc. Stock
Aphria, Inc.
SupplierCustomer-0,290,340,36-0,75
1

Most common questions regarding Medlab Clinical

What values and corporate philosophy does Medlab Clinical represent?

Medlab Clinical Ltd is a renowned company that upholds its core values and corporate philosophy with utmost dedication. The company firmly believes in promoting innovative and evidence-based medical research to improve patient outcomes. With a focus on scientifically driven products, Medlab Clinical Ltd strives to develop and deliver advanced therapeutic solutions in the field of medical science. The company values integrity, commitment, and excellence, as it strives to provide cutting-edge diagnostics and personalized medicine. Medlab Clinical Ltd's dedication to upholding these values has made it a trusted name in the healthcare industry, offering high-quality solutions for better patient care.

In which countries and regions is Medlab Clinical primarily present?

Medlab Clinical Ltd is primarily present in Australia and New Zealand.

What significant milestones has the company Medlab Clinical achieved?

Some significant milestones achieved by Medlab Clinical Ltd include the successful completion of a Phase 2 trial for their lead drug candidate, NRGBiotic, for managing depression symptoms. The company has also received various regulatory approvals and successfully launched several products, including Nanabis, a cannabis-based product for pain management. Medlab Clinical Ltd has established collaborations with prestigious research institutions and universities worldwide, contributing to advancements in medical research. The company continues to expand its global reach, with strategic partnerships and acquisitions, positioning itself as an innovative leader in the field of personalized medicine and nutraceuticals.

What is the history and background of the company Medlab Clinical?

Medlab Clinical Ltd is an Australian biotechnology company specializing in developing and commercializing novel therapeutic products for chronic diseases. Established in 2012, Medlab Clinical has rapidly emerged as a leader in the medical research and development sector. With a strong focus on scientific innovation, the company aims to improve patient outcomes through its advanced drug delivery systems and targeted treatments. Medlab Clinical has garnered recognition for its cutting-edge medical advancements, including patented NanoCelle™ technology. With a commitment to research excellence and a dedicated team of experts, Medlab Clinical continues to revolutionize the field of biotechnology and pave the way for groundbreaking medical solutions.

Who are the main competitors of Medlab Clinical in the market?

The main competitors of Medlab Clinical Ltd in the market include companies such as Sonic Healthcare Limited, Healius Limited, Integral Diagnostics Limited, and Capitol Health Limited. These companies also operate in the medical diagnostics and healthcare industry, offering similar services and solutions. Despite facing competition, Medlab Clinical Ltd has established a strong presence and reputation through its innovative offerings, research collaborations, and dedication to improving patient outcomes.

In which industries is Medlab Clinical primarily active?

Medlab Clinical Ltd is primarily active in the healthcare and biotechnology industries.

What is the business model of Medlab Clinical?

The business model of Medlab Clinical Ltd is focused on innovative medical research and the development of therapeutic formulations. As a leading Australian biotech company, Medlab Clinical specializes in developing and commercializing nutraceuticals, pharmaceuticals, and diagnostic tools to improve patient outcomes. Medlab Clinical aims to leverage its expertise in advanced delivery platforms and nutraceutical products to address various health conditions, including pain management, depression, and chronic diseases. By prioritizing research-backed solutions and strategic collaborations, Medlab Clinical aims to transform healthcare through evidence-based treatments and personalized medicine.

What is the P/E ratio of Medlab Clinical 2024?

The Medlab Clinical P/E ratio is -0.69.

What is the P/S ratio of Medlab Clinical 2024?

The Medlab Clinical P/S ratio is 3.44.

What is the Quality Investing of Medlab Clinical?

The Quality Investing for Medlab Clinical is 2/10.

What is the revenue of Medlab Clinical 2024?

The expected Medlab Clinical revenue is 4.38 M AUD.

How high is the profit of Medlab Clinical 2024?

The expected Medlab Clinical profit is -21.74 M AUD.

What is the business model of Medlab Clinical

Medlab Clinical Ltd is an Australian company specializing in the development and provision of clinical diagnostic solutions for medical professionals. The company operates in three main divisions: diagnostic services, biotechnology, and research and development. The diagnostic services provide a variety of laboratory tests for medical conditions, including hormone tests, immune tests, and microbiology tests. The biotechnology division focuses on developing groundbreaking drugs and therapies for serious diseases such as inflammation and cancer. The research and development division invests in innovative technologies and products to meet the needs of medical professionals and their patients. Medlab Clinical offers a wide range of products and services, including probiotics for digestive and gut health, skin-friendly nutraceuticals, and blood tests for various medical conditions. The company's strong business model is based on innovation, research, and customer service. It aims to maintain its reputation as a leading provider of clinical diagnostic solutions and biotechnological developments through continuous innovation and excellent customer satisfaction.

What is the Medlab Clinical dividend?

Medlab Clinical pays a dividend of 0 AUD distributed over payouts per year.

How often does Medlab Clinical pay dividends?

The dividend cannot currently be calculated for Medlab Clinical or the company does not pay out a dividend.

What is the Medlab Clinical ISIN?

The ISIN of Medlab Clinical is AU000000MDC8.

What is the Medlab Clinical WKN?

The WKN of Medlab Clinical is A14R7W.

What is the Medlab Clinical ticker?

The ticker of Medlab Clinical is MDC.AX.

How much dividend does Medlab Clinical pay?

Over the past 12 months, Medlab Clinical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Medlab Clinical is expected to pay a dividend of 0 AUD.

What is the dividend yield of Medlab Clinical?

The current dividend yield of Medlab Clinical is .

When does Medlab Clinical pay dividends?

Medlab Clinical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Medlab Clinical?

Medlab Clinical paid dividends every year for the past 0 years.

What is the dividend of Medlab Clinical?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Medlab Clinical located?

Medlab Clinical is assigned to the 'Health' sector.

Wann musste ich die Aktien von Medlab Clinical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Medlab Clinical from 11/8/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 11/8/2024.

When did Medlab Clinical pay the last dividend?

The last dividend was paid out on 11/8/2024.

What was the dividend of Medlab Clinical in the year 2023?

In the year 2023, Medlab Clinical distributed 0 AUD as dividends.

In which currency does Medlab Clinical pay out the dividend?

The dividends of Medlab Clinical are distributed in AUD.

All fundamentals about Medlab Clinical

Our stock analysis for Medlab Clinical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medlab Clinical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.